EN DE
Watch aXichem AB for free: we tell you when fair value or trend changes.
Data-driven stock valuation

aXichem AB (AXIC-A) fair value: what the stock is really worth

As of Oct 28, 2026: fair value (intrinsic value) of aXichem AB stock SEK 0.84, price SEK 1.74, upside -51.5%, quality 31 out of 100. Rating: strongly overvalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value 30%+ above price?No
  2. Quality 50+?No
  3. In an uptrend?No
  4. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Basic Materials SE · ISIN SE0005250719

AA aXichem AB logo Thin data Oct 25, 2026

aXichem AB

AXIC-A · ST

Weakest SetupStrongly overvalued and low quality.

Our calculation puts a fair price 51% below what the stock costs today.

Mixed Growth (revenue 5y +72.0 %/yr in SEK)
Fair value kr 0.8415 · Strongly overvalued (−51.5%)
Quality 31/100
Loss-making · -95.4% net margin (TTM)
Negative free cash flow
Trails peers (0/9)
Narrow moat 12/100
Thin data
⟳ Cyclical⚠ Dilution
Watch aXichem AB for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

kr 31.14 kr 1.06 Fair Value kr 0.8415 Jul 2021 Oct 2026

White line = price, green steps = our fair value per fiscal year. As of Oct 25, 2026.

How to read this chart

60‑month range kr 1.06 – kr 31.14 · fair‑value band kr 0.5865 – kr 1.10 · the kr 1.74 price screens above the kr 0.8415 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Oct 25, 2026.

Follow aXichem in your weekly email

Every Wednesday you see whether aXichem is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

aXichem AB, a biotechnology company, engages in the development of natural analogue ingredients in Sweden.

Show moreShow less

The company offers aXivite, a natural analogue capsaicin solution for a range of dietary health applications; aXiphen-bio, a bio-repellent for antifouling protection for vessels and marine installations, pest control in agriculture and forestry, and pest control for cable installations in buildings and underground cables; and aXiphen-feed, a solution for enhanced health for chickens, hens, pigs, and piglets.

The company was founded in 1999 and is based in Malmö, Sweden.

Stock analysis

aXichem AB (AXIC-A) currently trades at kr 1.74, while our model-based Fair Value estimate is kr 0.8415, 51.5% below the price, so the stock looks overvalued today.

Show more

Valuation

How firm this estimate is: it rests on 1 models at a data quality of 96/100, which puts the data coverage at low.

Scenario range: kr 0.5865 (bear) to kr 1.10 (bull), the price of kr 1.74 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 31/100 (below-average quality), in the Basic Materials sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

aXichem AB reported revenue of 18.4M SEK in FY2025 versus 4.4M SEK in FY2021, a compound +43.4%/yr. Reported net income was −17.6M SEK in FY2025.

Key figures

Market cap 118M SEK (≈ $11.9M) Micro · P/S ratio 7.91 · EPS (TTM) kr −0.2500 · Net margin −95.4% · Return on equity −26.7% · Return on assets (EBIT) −25.3% · Operating margin −106% · Revenue (TTM) 16.3M SEK.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 12 out of 100 (medium confidence).

What moves the price

The share trades about 53% below its 52-week high and 48% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Basic Materials peers we cover trades at −55% fair-value upside, at −51%, AXIC-A screens cheaper than that median.

Fair Value models

Bear kr 0.5865 Fair Value kr 0.8415 Bull kr 1.10
Price kr 1.74 · Upside -51.5%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
NCAV (Graham) kr 0.0700 kr 0.1000 kr 0.1300 52
All 1 models by family
Asset-Based
NCAV (Graham) kr 0.0700 kr 0.1000 kr 0.1300 52

The fair value above starts from this blend and is adjusted for dilution from new shares.

Open the full fair value analysis →

Quality Score breakdown

Overall quality 31/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 3
How much profit the company makes from its sales and capital
Quality Growth 60
Are margins and returns getting better?
Cashflow 3
Do the profits arrive as real cash?
Financial strength 78
Debt, balance sheet and risk of trouble
Investment 51
Does it invest with discipline instead of growing at any price?
Low Volatility 50
How calm the share price moves, does not count
Momentum 31
Price trend of the last 3 to 12 months, does not count
Near the 52-week high 11
Distance to the 52-week high, does not count
New shares 0
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 29/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+115.2%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+54.4%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+72.0%
Start year 2020 (pandemic)
Revenue growth 11 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+42.5%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−1,101.3% (2020) → −91.8% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

AXIC-A screens overvalued: fair value 51% below the price. Compare with Linde plc →

Compare aXichem AB with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 726 stocks

Beats the industry median on 0/8 measures
Overall it trails its industry peers.
Valuation
Quality Score 31 · Bottom 25%
Fair Value upside −51.5% · Below median
Profitability
Return on assets −28.9% · Bottom 25%
Net margin (12 months) −95.4% · Bottom 25%
Operating margin (12 months) −106.4% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) −39.4% · Bottom 25%

Valuation Multiplesvs Specialty Chemicals median · lower = cheaper

P/B 2.22× · Pricier than median
P/S (12 months) 7.22× · Priciest 25%

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Wanhua Chemical Group 600309 ¥70.33 ¥68.03 −3% vs AXIC-A
Linde plc LIN $507.56 $444.78 −12% vs AXIC-A
PPG Industries, Inc PPG $113.44 $77.19 −32% vs AXIC-A
Asian Paints Limited ASIANPAINT ₹2,277 ₹1,479 −35% vs AXIC-A
The Sherwin-Williams Company SHW $326.01 $145.67 −55% vs AXIC-A
Givaudan SA GIVN CHF 3,944 CHF 1,554 −61% vs AXIC-A
EMS-CHEMIE HOLDING AG EMSN CHF 850.50 CHF 284.63 −67% vs AXIC-A
Ecolab Inc ECL $291.27 $96.56 −67% vs AXIC-A
DSM-Firmenich AG DSFIR CHF 100.90 CHF 29.15 −71% vs AXIC-A
International Flavors & Fragrances Inc IFF $93.21 $22.45 −76% vs AXIC-A

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Peter Lynch Fair Value Formula &…Calculator with industry benchmark
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

aXichem AB · Fair Value
kr 0.8415 −51%Fair Value
Calculator →

Cite: Fair Value Calculator (2026). "aXichem AB Fair Value". https://www.fairvalue-calculator.com/stock/AXIC-A

Frequently asked questions

Is aXichem AB (AXIC-A) overvalued or undervalued?
As of Oct 25, 2026, our model estimates a fair value of kr 0.8415 versus a price of kr 1.74, about −51% upside (overvalued).
What is the fair value of AXIC-A?
Our model-based fair value for aXichem AB is kr 0.8415 (as of Oct 25, 2026), built from audited fundamentals. The current price: kr 1.74.
What is the quality score of AXIC-A?
aXichem AB has a Quality Score of 31/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for aXichem AB (AXIC-A)?
Our model-based price target is the fair value of kr 0.8415 (as of Oct 25, 2026) from 1 valuation models. Cautious scenario kr 0.5865, optimistic scenario kr 1.10. It is a calculation from audited fundamentals, not an analyst target.
What is the aXichem AB stock forecast for 2026?
Our models put fair value at kr 0.8415, about −51% upside versus a price of kr 1.74 (overvalued). Cautious scenario kr 0.5865, optimistic scenario kr 1.10. The calculation is refreshed regularly with new filings.
What is the revenue of aXichem AB (AXIC-A)?
aXichem AB reported trailing-twelve-month revenue of about 16.3M SEK (latest available figure, as of Oct 25, 2026).
What is the intrinsic value of aXichem AB (AXIC-A)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For aXichem AB it is kr 0.8415 per share (as of Oct 25, 2026), against a price of kr 1.74. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).
Is aXichem AB stock overvalued or undervalued in 2026?
As of Oct 25, 2026, AXIC-A trades above its calculated fair value: price kr 1.74, fair value kr 0.8415, a gap of about −51% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of AXIC-A?
No. The price is what the market pays today (kr 1.74); the fair value is what the company's own numbers justify (kr 0.8415). For aXichem AB the two are kr 0.8935 per share apart. That gap is exactly why we show both numbers side by side.
How much is aXichem AB worth?
The market values aXichem AB at about 118M SEK (market capitalisation, as of Oct 25, 2026). Per share that is kr 1.74; our models calculate a fair value of kr 0.8415 per share.
What do the bullish and bearish scenarios say about AXIC-A?
Our models span a range for aXichem AB: cautious scenario kr 0.5865, base kr 0.8415, optimistic kr 1.10 per share (as of Oct 25, 2026, price kr 1.74). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of aXichem AB (AXIC-A)?
Balance-sheet figures for aXichem AB (as of Oct 25, 2026): return on equity −26.7%. They feed the Quality Score of 31/100, which measures business quality independently of the share price.
How far is AXIC-A from its 52-week high?
aXichem AB trades at kr 1.74, about 53% below its 52-week high of kr 3.70 and 48% above the low of kr 1.17 (as of Oct 28, 2026). Distance from the high says nothing about value: that is what the fair value of kr 0.8415 is for.
Which stocks are comparable to aXichem AB?
From the same area (Basic Materials) we also value Linde plc, Ecolab Inc, The Sherwin-Williams Company, Givaudan SA, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is aXichem AB stock attractive at the current price?
The data as of Oct 25, 2026: price kr 1.74, calculated fair value kr 0.8415 (−51%), Quality Score 31/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of AXIC-A calculated?
We run aXichem AB through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of kr 0.8415, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.4 % above its aggregate fair value. aXichem AB itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of aXichem AB (AXIC-A)?
The closing price on Oct 28, 2026 was kr 1.74. Our model-based fair value is kr 0.8415, about −51% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with aXichem AB right now?
The price sits above even our optimistic bull case (kr 1.10). The favourable scenario is already priced in. Weak quality (31/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. A fairly wide model range (kr 0.5865 to kr 1.10) leaves room in how you read the outcome.

Key figures of aXichem AB

How large is the market capitalisation of aXichem AB (AXIC-A)?
The market capitalisation of aXichem AB is 118M SEK (≈ $11.9M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of aXichem AB (AXIC-A)?
The price-to-sales ratio of aXichem AB is 7.91 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of aXichem AB (AXIC-A)?
Earnings per share at aXichem AB are kr −0.2500. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of aXichem AB (AXIC-A)?
The net margin of aXichem AB is −95.4% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of aXichem AB (AXIC-A)?
The return on equity (ROE) of aXichem AB is −26.7% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of aXichem AB (AXIC-A)?
On an EBIT basis the return on assets of aXichem AB is −25.3% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of aXichem AB (AXIC-A)?
The operating margin of aXichem AB is −106% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at aXichem AB (AXIC-A)?
Revenue at aXichem AB is growing −39.4% versus a year earlier (3y avg +54.4%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does aXichem AB (AXIC-A) generate?
The free cash flow of aXichem AB is −16.0M SEK (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does aXichem AB (AXIC-A) carry?
The net debt of aXichem AB is 1.6M SEK (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch aXichem AB in the live analysis

One click puts aXichem AB on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 28,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.